Capricor Therapeutics

1 follower

‌

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.

Industries

Headquarters

Employees

Links

Org chart

Linda Marbán

Chief Executive Officer

Linda Marbán

Collapse

Aj Bergmann

Chief Financial Officer

Kristi A. H. Elliott

Chief Science Officer

Mark Awadalla

Vice President Clinical Research & Development Operations

Yushi Feng

VP of Regulatory Affairs

Jonathan Tayco

Vice President Of Program Management, Operations And Quality

Joe Z.

Senior IP Counsel

Teams

+24

Research and Development

27 members

Leadership Team

3 members

Finance and Accounting

3 members

Similar companies

Cargo

1 follower

Apogee Therapeutics

1 follower

Imvax

1 follower

Elektrofi

1 follower

Cellares

2 followers

Thermo Fisher Scientific

149 followers

Gilead Sciences

121 followers

Biogen

108 followers

Regeneron

89 followers

Akari Therapeutics

1 follower

Vertex Pharmaceuticals

50 followers

Discover companies